Promethazine

Aura

Charleston Laboratories, IncSmall moleculePhase 2Dormant

B

57/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 42/ 100
Competitive Position: 95/ 100

Competitive context

2 Active assets in the Aura cohort.

Asset / Sponsor	Phase	Rating
CL-H1T Charleston Laboratories, Inc	Phase 2	B
Prochlorperazine Alexza Pharmaceuticals, Inc.	Phase 2	B
Inhaled Pcz Alexza Pharmaceuticals, Inc.	Phase 2	B
Treximet® Danish Headache Center	Phase 2	B
Levcromakalim Danish Headache Center	N/A	D

Same molecule, other indications

Promethazine is also rated in:

disruptive behavior disorderDormant

BB

Indicative ·

64 / 100

migraine without auraDormant

B

Indicative ·

62 / 100

physiological malfunction arising from mental factorDormant

B

Indicative ·

60 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.